Video Education with Result Dependent Disclosure to Improve Genetic Testing Uptake and Patient Outcomes, VERDI Study

Inclusion Criteria

• PATIENT INTERVIEWS: Age >= 18 years
• PATIENT INTERVIEWS: Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma
• PATIENT INTERVIEWS: Ability to understand spoken or written English or Spanish in a healthcare context
• PATIENT INTERVIEWS: Ability to understand and the willingness to sign a written informed consent document
• PATIENT INTERVIEWS: Black or Latinx (qualitative assessment study only)
• RANDOMIZED CONTROLLED TRIAL: Age ≥ 18 years
• RANDOMIZED CONTROLLED TRIAL: Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma
• RANDOMIZED CONTROLLED TRIAL: Ability to understand spoken or written English or Spanish in a healthcare context
• RANDOMIZED CONTROLLED TRIAL: Ability to understand and the willingness to sign a written informed consent document
• GENETIC COUNSELOR INTERVIEWS: Age >= 18 years
• GENETIC COUNSELOR INTERVIEWS: Licensed genetic counselor (GC) practitioner
• GENETIC COUNSELOR INTERVIEWS: Experience working with patients diagnosed with cancer
• GENETIC COUNSELOR INTERVIEWS: Ability to understand written and spoken English
• GENETIC COUNSELOR INTERVIEWS: Ability to understand the process and goals of the study
• GENETIC COUNSELOR INTERVIEWS: Willingness to participate in the study
• GENETIC COUNSELOR SURVEY: Age >= 18 years
• GENETIC COUNSELOR SURVEY: Sees an average of at least three patients per week for cancer genetic counseling
• GENETIC COUNSELOR SURVEY: Ability to understand written and spoken English
• GENETIC COUNSELOR SURVEY: Ability to understand the process and goals of the study
• GENETIC COUNSELOR SURVEY: Willingness to participate in the study

Exclusion Criteria

• PATIENT INTERVIEWS: Prior germline cancer panel genetic testing
• PATIENT INTERVIEWS: Active hematologic malignancy (e.g. chronic lymphocytic leukemia)
• PATIENT INTERVIEWS: Currently pregnant
• PATIENT INTERVIEWS: Currently incarcerated
• RANDOMIZED CONTROLLED TRIAL: Prior germline cancer panel genetic testing
• RANDOMIZED CONTROLLED TRIAL: Active hematologic malignancy (e.g. chronic lymphocytic leukemia)
• RANDOMIZED CONTROLLED TRIAL: Currently pregnant, per verbal participant report
• RANDOMIZED CONTROLLED TRIAL: Currently incarcerated